A 1-Year Randomized Study of the Clinical and Confocal Effects of Tafluprost and Latanoprost in Newly Diagnosed Glaucoma Patients
Conclusions
The two study treatments had similar clinical effects, but tafluprost had a more favorable profile for some confocal parameters of the cornea.
Funding
Merck Sharp & Dohme International.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology | Eyes | Glaucoma | Latanoprost | Merck | Opthalmology | Statistics | Study